Neogen Corporation Intangible Assets, Net (Excluding Goodwill)
Neogen Corporation (NEOG) had Intangible Assets, Net (Excluding Goodwill) of $1.44 billion as of 2025-02-28, per its 10-Q filed 2025-04-09.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2025-04-09
- 2025-02-28: Intangible Assets, Net (Excluding Goodwill) $1.44B.
- 2024-11-30: Intangible Assets, Net (Excluding Goodwill) $1.46B.
- 2024-08-31: Intangible Assets, Net (Excluding Goodwill) $1.49B.
- 2024-05-31: Intangible Assets, Net (Excluding Goodwill) $1.51B.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2025-02-28 | $1.44B 10-Q · filed 2025-04-09 |
| 2024-11-30 | $1.46B 10-Q · filed 2025-01-15 |
| 2024-08-31 | $1.49B 10-Q · filed 2024-10-10 |
| 2024-05-31 | $1.51B 10-Q · filed 2025-04-09 |
| 2024-02-29 | $1.54B 10-Q · filed 2024-04-09 |
| 2023-11-30 | $1.56B 10-Q · filed 2024-01-09 |
| 2023-08-31 | $1.59B 10-Q · filed 2023-10-10 |
| 2023-05-31 | $1.61B 10-Q · filed 2024-04-09 |
| 2016-02-29 | $23.07M 10-Q · filed 2016-03-31 |
| 2015-11-30 | $23.57M 10-Q · filed 2016-01-08 |
| 2015-08-31 | $24.88M 10-Q · filed 2015-09-30 |
| 2015-05-31 | $24.17M 10-Q · filed 2016-03-31 |
| 2015-02-28 | $21.85M 10-Q · filed 2015-04-01 |
| 2014-11-30 | $23.94M 10-Q · filed 2014-12-30 |
| 2014-08-31 | $24.54M 10-Q · filed 2014-09-30 |
| 2014-05-31 | $25.23M 10-K · filed 2015-07-30 |
| 2014-02-28 | $23.61M 10-Q · filed 2014-04-04 |
| 2013-11-30 | $18.14M 10-Q · filed 2014-01-09 |
| 2013-08-31 | $13.72M 10-Q · filed 2013-09-30 |
| 2013-05-31 | $12.35M 10-K · filed 2014-07-30 |
| 2012-05-31 | $10.83M 10-K · filed 2013-07-30 |
| 2012-02-29 | $7.03M 10-Q · filed 2012-03-30 |
| 2011-11-30 | $7.02M 10-Q · filed 2011-12-30 |
| 2011-08-31 | $6.76M 10-Q · filed 2011-09-30 |
| 2011-05-31 | $6.06M 10-Q · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |